We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$217M
AUM Growth
+$16.6M
Cap. Flow
+$4.19M
Cap. Flow %
1.93%
Top 10 Hldgs %
36.04%
Holding
132
New
21
Increased
23
Reduced
25
Closed
21

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$2.94M
2
C icon
Citigroup
C
+$2.88M
3
LRCX icon
Lam Research
LRCX
+$2.41M
4
CRM icon
Salesforce
CRM
+$2.25M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.11M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.14M
2
SBUX icon
Starbucks
SBUX
+$2.61M
3
WRB icon
W.R. Berkley
WRB
+$2.25M
4
HSY icon
Hershey
HSY
+$2.14M
5
DG icon
Dollar General
DG
+$2M

Sector Composition

Rank Sector Weight
1 Technology 29.19%
2 Communication Services 12.29%
3 Financials 11.61%
4 Healthcare 11.04%
5 Consumer Discretionary 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
101
JPMorgan Chase
JPM
$956B
$259K 0.12%
1,637
PWR icon
102
Quanta Services
PWR
$99.4B
$251K 0.12%
2,192
VRTX icon
103
Vertex Pharmaceuticals
VRTX
$133B
$250K 0.12%
1,138
-2,600
-70% -$506K
SWKS icon
104
Skyworks Solutions
SWKS
$10.4B
$240K 0.11%
1,550
-1,400
-47% -$224K
FDX icon
105
FedEx
FDX
$76.9B
$232K 0.11%
+897
New +$215K
T icon
106
AT&T
T
$165B
$220K 0.1%
11,850
-33,696
-74% -$630K
CTRA
107
DELISTED
Coterra Energy
CTRA
$205K 0.09%
10,801
TH icon
108
Target Hospitality
TH
$1.6B
$37K 0.02%
+10,400
New +$40K
DRRX
109
DELISTED
DURECT Corp
DRRX
$17K 0.01%
1,772
TXMD icon
110
TherapeuticsMD
TXMD
$24M
$13K 0.01%
751
BXRX
111
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$3K ﹤0.01%
11
ACN icon
112
Accenture
ACN
$109B
-3,200
Closed -$1.02M
BMRN icon
113
BioMarin Pharmaceuticals
BMRN
$13.3B
-4,241
Closed -$328K
CCI icon
114
Crown Castle
CCI
$31.3B
-1,400
Closed -$243K
DG icon
115
Dollar General
DG
$27B
-9,410
Closed -$2M
DLTR icon
116
Dollar Tree
DLTR
$24.9B
-5,356
Closed -$513K
EG icon
117
Everest Group
EG
$14.2B
-1,981
Closed -$497K
ETR icon
118
Entergy
ETR
$49.3B
-15,926
Closed -$791K
LEVI icon
119
Levi Strauss
LEVI
$9.09B
-34,150
Closed -$837K
LLY icon
120
Eli Lilly
LLY
$1.1T
-5,450
Closed -$1.26M
MAS icon
121
Masco
MAS
$14.7B
-29,635
Closed -$1.65M
MRK icon
122
Merck
MRK
$323B
-68,406
Closed -$5.14M
MU icon
123
Micron Technology
MU
$972B
-6,050
Closed -$429K
ORCL icon
124
Oracle
ORCL
$435B
-6,400
Closed -$558K
QCOM icon
125
Qualcomm
QCOM
$170B
-7,178
Closed -$926K

Similar funds

Stoneridge Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Stoneridge Investment Partners held 132 positions worth $217M, up 8.3% from $200M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Stoneridge Investment Partners's Q4 2021 filing shows 21 new, 23 increased, 25 reduced and 21 closed positions. Its largest new stake was Lam Research: 38,440 shares worth $2.76M. The largest sale was Merck, an estimated $5.14M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Communication Services and Financials.

  • Stoneridge Investment Partners's largest Q4 2021 buy was Lam Research: 38,440 shares worth $2.76M.
  • Stoneridge Investment Partners added most to Baxter International in Q4 2021, an estimated $2.94M increase.
  • Stoneridge Investment Partners's biggest Q4 2021 reduction was W.R. Berkley, cutting an estimated $2.25M.
  • Stoneridge Investment Partners fully exited Merck in Q4 2021, selling an estimated $5.14M.
  • Stoneridge Investment Partners's ten largest holdings make up 36% of its $217M portfolio in Q4 2021.
  • Stoneridge Investment Partners opened 21 new positions and closed 21 in Q4 2021.
  • Stoneridge Investment Partners's portfolio value rose 8.3% quarter-over-quarter to $217M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2021, filed 2 Feb 2022.